Skip to main content

Pfizer says omicron shots substantially boosted antibodies against BA.5 subvariant in early human data

The FDA has authorized Pfizer's boosters without direct human data on how they perform against the omicron BA.5 subvariant.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.